ATE52141T1 - Immuntest, mittel und verfahren zur bestimmung von natuerlichem und ungewoehnlichem humanprothrombin. - Google Patents
Immuntest, mittel und verfahren zur bestimmung von natuerlichem und ungewoehnlichem humanprothrombin.Info
- Publication number
- ATE52141T1 ATE52141T1 AT85307407T AT85307407T ATE52141T1 AT E52141 T1 ATE52141 T1 AT E52141T1 AT 85307407 T AT85307407 T AT 85307407T AT 85307407 T AT85307407 T AT 85307407T AT E52141 T1 ATE52141 T1 AT E52141T1
- Authority
- AT
- Austria
- Prior art keywords
- immunotest
- methods
- human prothrombin
- determining natural
- unusual human
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3038—Kidney, bladder
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/807—Apparatus included in process claim, e.g. physical support structures
- Y10S436/808—Automated or kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/825—Pretreatment for removal of interfering factors from sample
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/661,187 US4769320A (en) | 1982-07-27 | 1984-10-15 | Immunoassay means and methods useful in human native prothrombin and human abnormal prothorombin determinations |
EP85307407A EP0182495B1 (de) | 1984-10-15 | 1985-10-15 | Immuntest, Mittel und Verfahren zur Bestimmung von natürlichem und ungewöhnlichem Human-Prothrombin |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE52141T1 true ATE52141T1 (de) | 1990-05-15 |
Family
ID=24652562
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT85307407T ATE52141T1 (de) | 1984-10-15 | 1985-10-15 | Immuntest, mittel und verfahren zur bestimmung von natuerlichem und ungewoehnlichem humanprothrombin. |
Country Status (5)
Country | Link |
---|---|
US (1) | US4769320A (de) |
EP (1) | EP0182495B1 (de) |
JP (1) | JPS61117457A (de) |
AT (1) | ATE52141T1 (de) |
DE (1) | DE3577233D1 (de) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6258938B1 (en) * | 1983-10-28 | 2001-07-10 | Ne Medical Center Hospital, Inc. | Method for the purification and isolation of blood clotting proteins using conformation specific antibodies |
DE3727610A1 (de) * | 1987-08-19 | 1989-03-02 | Behringwerke Ag | Synthetische peptide, gegen diese gerichtete antikoerper und deren verwendung |
US5147779A (en) * | 1988-06-01 | 1992-09-15 | Miles Inc. | Method for evaluating immunogenicity |
US5217870A (en) * | 1989-04-28 | 1993-06-08 | Biogen, Inc. | Monoclonal antibodies against CDX |
US5272263A (en) * | 1989-04-28 | 1993-12-21 | Biogen, Inc. | DNA sequences encoding vascular cell adhesion molecules (VCAMS) |
US5532136A (en) * | 1993-06-22 | 1996-07-02 | Bionebraska, Inc. | Monoclonal antibody assay and kit for detecting metal cations in body fluids |
US20020040008A1 (en) * | 1995-01-24 | 2002-04-04 | Wagner Denisa D. | Method for treating and preventing atherosclerosis |
US6325651B1 (en) * | 1996-07-27 | 2001-12-04 | Moriyama Sangyo Kabushiki Kaisha | Light emitting device, socket device and lighting device |
US5935802A (en) * | 1998-08-10 | 1999-08-10 | Evanston Northwestern Healthcare Research Institute | Method of assaying a blood sample for prothrombin |
DE19941447C2 (de) * | 1999-08-14 | 2002-06-27 | November Ag Molekulare Medizin | Verfahren zur indirekten Bestimmung des Blutgerinnungsstatus |
JP2003507712A (ja) | 1999-08-14 | 2003-02-25 | ノヴェンバー アクティエンゲゼルシャフト ゲゼルシャフト フューア モレクラーレ メディツィーン | 血液凝固状態の間接的測定方法 |
AU2003296086A1 (en) * | 2002-12-26 | 2004-07-22 | Nitto Boseki Co., Ltd. | Immunoassay method and kit to be used therein |
KR20220162801A (ko) | 2008-04-11 | 2022-12-08 | 추가이 세이야쿠 가부시키가이샤 | 복수 분자의 항원에 반복 결합하는 항원 결합 분자 |
TWI440469B (zh) | 2008-09-26 | 2014-06-11 | Chugai Pharmaceutical Co Ltd | Improved antibody molecules |
US8283162B2 (en) | 2009-03-10 | 2012-10-09 | Abbott Laboratories | Antibodies relating to PIVKAII and uses thereof |
EP2647706B1 (de) * | 2010-11-30 | 2023-05-17 | Chugai Seiyaku Kabushiki Kaisha | Antigenbindende moleküle zur wiederholten bindung an mehrere antigenmoleküle |
EP2679681B2 (de) | 2011-02-25 | 2023-11-15 | Chugai Seiyaku Kabushiki Kaisha | FcgammaRIIB-spezifischer Fc Antikörper |
TW201817744A (zh) | 2011-09-30 | 2018-05-16 | 日商中外製藥股份有限公司 | 具有促進抗原清除之FcRn結合域的治療性抗原結合分子 |
WO2013047748A1 (ja) | 2011-09-30 | 2013-04-04 | 中外製薬株式会社 | 複数の生理活性を有する抗原の消失を促進する抗原結合分子 |
KR102515796B1 (ko) | 2014-12-19 | 2023-03-30 | 추가이 세이야쿠 가부시키가이샤 | 항-c5 항체 및 그의 사용 방법 |
KR20180054923A (ko) | 2014-12-19 | 2018-05-24 | 추가이 세이야쿠 가부시키가이샤 | 항-마이오스타틴 항체, 변이체 Fc 영역을 함유하는 폴리펩타이드, 및 사용 방법 |
MX2017008978A (es) | 2015-02-05 | 2017-10-25 | Chugai Pharmaceutical Co Ltd | Anticuerpos que comprenden un dominio de union al antigeno dependiente de la concentracion ionica, variantes de la region fc, antiocuerpor de union a interleucina 8 (il-8) y usos de los mismos. |
EP4269440A3 (de) | 2015-02-27 | 2024-02-28 | Chugai Seiyaku Kabushiki Kaisha | Zusammensetzung zur behandlung von il-6-assoziierten erkrankungen |
US11359009B2 (en) | 2015-12-25 | 2022-06-14 | Chugai Seiyaku Kabushiki Kaisha | Anti-myostatin antibodies and methods of use |
CN107727864A (zh) * | 2016-07-01 | 2018-02-23 | 首都医科大学附属北京佑安医院 | 一种检测血清中异常脱羧凝血酶原的蛋白芯片、试剂盒及其制备方法 |
US11053308B2 (en) | 2016-08-05 | 2021-07-06 | Chugai Seiyaku Kabushiki Kaisha | Method for treating IL-8-related diseases |
WO2018139623A1 (en) | 2017-01-30 | 2018-08-02 | Chugai Seiyaku Kabushiki Kaisha | Anti-sclerostin antibodies and methods of use |
US11851486B2 (en) | 2017-05-02 | 2023-12-26 | National Center Of Neurology And Psychiatry | Method for predicting and evaluating therapeutic effect in diseases related to IL-6 and neutrophils |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6060557A (ja) * | 1983-09-13 | 1985-04-08 | Eisai Co Ltd | Pivka−2の測定方法および試薬 |
-
1984
- 1984-10-15 US US06/661,187 patent/US4769320A/en not_active Expired - Lifetime
-
1985
- 1985-10-15 DE DE8585307407T patent/DE3577233D1/de not_active Expired - Fee Related
- 1985-10-15 JP JP60229763A patent/JPS61117457A/ja active Granted
- 1985-10-15 AT AT85307407T patent/ATE52141T1/de not_active IP Right Cessation
- 1985-10-15 EP EP85307407A patent/EP0182495B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0182495B1 (de) | 1990-04-18 |
JPH0441000B2 (de) | 1992-07-06 |
US4769320A (en) | 1988-09-06 |
JPS61117457A (ja) | 1986-06-04 |
DE3577233D1 (de) | 1990-05-23 |
EP0182495A1 (de) | 1986-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE52141T1 (de) | Immuntest, mittel und verfahren zur bestimmung von natuerlichem und ungewoehnlichem humanprothrombin. | |
DE3586159T2 (de) | Zusammensetzung und verfahren zur differenzierung von weissen blutzellen. | |
DE68923981T2 (de) | Verfahren zur Bestimmung von Textteilen und Verwendung. | |
DE68903884T2 (de) | Mittel und methode zur bestimmung von spurenmengen an proteinen. | |
ATA328286A (de) | Zell-linien und verfahren zur herstellung von humanen monoklonalen antikörpern sowie kit und verfahren zur bestimmung der anwesenheit von p.aeruginosa | |
ATE148923T1 (de) | Funktioneller test und reagenz zur bestimmung von fibrinogen | |
DE3863285D1 (de) | Verfahren und reagenz zur bestimmung von persaeuren. | |
AT389590B (de) | Verfahren zur kontinuierlichen, quantitativen bestimmung von schwefeldioxid und anordnung zur durchfuehrung des verfahrens | |
AT363617B (de) | Verfahren zur direkten bestimmung von eisen im blutserum und reagens zur durchfuehrung des verfahrens | |
ATE48037T1 (de) | Verfahren und reagenz zur verwendung zur bestimmung von pivka-ii. | |
DE3485615D1 (de) | Reinigung eines krebsassoziierten proteins und herstellung eines antikoerpers dazu. | |
DE3668068D1 (de) | Mittel und verfahren zur bestimmung von calcium. | |
DE3889765T2 (de) | Reagens und Verfahren zur Bestimmung von Kationen. | |
DE3580771D1 (de) | Standardmaterial zur messung von immunologischen komplexen und verfahren zur messung von immunologischen komplexen. | |
DD133594A5 (de) | Verfahren und mittel zur bestimmung von hydroperoxiden | |
DE3777460D1 (de) | Verfahren zur bestimmung von leitendem material in glasfasern und geraet dazu. | |
AT362530B (de) | Verfahren und reagens zur bestimmung von glutamat-oxalacetat-transaminase und glutamat- -pyruvat-transaminase | |
DE3787706T2 (de) | Verfahren zur quantitativen Bestimmung der Antigene und Antikörper. | |
DE3785380D1 (de) | Analytische zusammensetzung, element und verfahren zur bestimmung von wasserstoffperoxid. | |
DE3678621D1 (de) | Verfahren und testzusammensetzung zur bestimmung von wasserstoffperoxyd. | |
ATA338987A (de) | Verfahren zur bestimmung von anti-p.falciparum- sporozoit-antikörpern im menschlichen blut | |
DE59208543D1 (de) | Künstliche Standard- und Kontrollseren zur Verwendung in Verfahren zur Bestimmung von Antikörpern | |
DE68907377D1 (de) | Agens und geraet zur bestimmung von antigenen oder antikoerpern. | |
DE3679763D1 (de) | Verfahren und zusammensetzungen zur bestimmung von heparin. | |
DE3883808T2 (de) | Testsatz, Extraktionsvorrichtung und Verfahren zur Bestimmung von Streptococcus-A-Antigen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |